Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Goodman, S.G.
10141  Ergebnisse:
Personensuche X
?
1

Two of a kind: mass and molar immunoassay-based lipoprotein..:

Szarek, M ; Steg, P G ; Jukema, J W...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
2

Lipoprotein(a) and the effect of alirocumab on coronary and..:

Steg, P ; Szarek, M ; Valgimigli, M...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
3

Causes of death in patients with atrial fibrillation and a ..:

Guimaraes, P ; Wojdyla, D M ; Alexander, J H...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
4

Endothelial progenitor cells overexpressing endothelial no-..:

Stewart, D.J. ; Kutryk, M.J. ; Ly, H.Q....
Cytotherapy.  23 (2021)  5 - p. S75 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Choice of P2Y12 inhibitor and clinical outcomes in the AUGU..:

Storey, R ; Alexander, J.H ; Wojdyla, D.M...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
6

Low-density lipoprotein cholesterol goal attainment and tre..:

Fairbairn, M ; Oh, P ; Goeree, R...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
7

Effect of alirocumab on incidence of atrial fibrillation af..:

Lopes, R ; Steg, P.G ; Bhatt, D.L...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
8

Transitioning a randomized controlled trial to a digital re..:

Avram, R ; So, D ; Iturriaga, E...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
9

Early coronary angiography in acute ischemic heart failure ..:

Kosyakovsky, L ; Wang, X ; Austin, P.C...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
10

Safety and efficacy of antithrombotic therapy according to ..:

Harskamp, R ; Lopes, R.D ; Li, Z...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
11

Low-density lipoprotein cholesterol <50 mg/dL is an appropr..:

Schwartz, G.G ; Szarek, M ; Bhatt, D.L...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
12

Differences in lipid treatment patterns in women versus men..:

Fairbairn, M ; Goeree, R ; Goodman, S.G...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
13

PCV32 ECONOMIC BURDEN OF ATHEROSCLEROTIC CARDIOVASCULAR DIS..:

Rogoza, R. ; Oh, P. ; Goodman, S.G....
Value in Health.  23 (2020)  - p. S96 , 2020
Link: https://doi.org/10.1016/..
 
?
14

4113Glucose lowering drugs or strategies, major adverse car..:

Ghosh-Swaby, O R ; Goodman, S G ; Leiter, L A...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
15

4115Effect of alirocumab on recurrent cardiovascular events..:

Diaz, R ; Li, Q H ; Bhatt, D L...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
1-15